WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Trading 05-19 09:36:42

33.460

+0.520

+1.58%

High33.640	Low32.680	Vol1.39M
Open32.680	D1 Closing32.940	Amplitude2.91%
Mkt Cap138.56B	Tradable Cap138.56B	Total Shares4.14B
T/O46.26M	T/O Rate0.03%	Tradable Shares4.14B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":33.46,"timestamp":1779154602733,"preClose":32.94,"halted":0,"volume":1392322,"delay":0,"changeRate":0.015786278081360145,"floatShares":4140999999,"shares":4140999999,"eps":1.336568173146952,"marketStatus":"Trading","change":0.52,"latestTime":"05-19 09:36:42","open":32.68,"high":33.64,"low":32.68,"amount":46262798,"amplitude":0.029144,"askPrice":33.48,"askSize":2500,"bidPrice":33.44,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":1.336568173146952,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1779163200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":32.94,"openAndCloseTimeList":[[1779154200000,1779163200000],[1779166800000,1779177600000]],"volumeRatio":2.272469,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.4704,"impliedVolPercentile":0.2389},"requestUrl":"/m/hq/s/02269/tweets","defaultTab":"tweets","newsList":[{"id":"2636025353","title":"Wuxi Biologics (Cayman) Stock Slips 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2636025353","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636025353?lang=en_us&edition=fundamental","pubTime":"2026-05-18 16:33","pubTimestamp":1779093180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. shed 2.2% to 32.94 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25675.18.Wuxi Biologics  Inc. closed 25% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 39.6 million shares, compared to the 50-day average of 28.6 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0819121731.USD","LU0043850808.USD","LU0348825331.USD","LU0051755006.USD","LU0181495838.USD","LU0417516902.SGD","BK1610","SG9999002562.SGD","LU1242518857.USD","LU1794554557.SGD","IE00B0JY6N72.USD","LU2039709279.SGD","LU0359202008.SGD","LU0516423174.USD","BK1521","LU1880383366.USD","LU1720050803.USD","LU0979878070.USD","BK1589","LU0307460666.USD","LU0359201612.USD","LU0417516738.SGD","BK1576","LU0516423091.SGD","LU1688375341.USD","LU3063872942.SGD","LU0456827905.SGD","LU0588546209.SGD","LU0326950275.SGD","BK1141","LU0140636845.USD","LU0456846285.SGD","LU0516422440.USD","LU0823426480.USD","LU0516422952.EUR","LU0327786744.USD","LU1242518931.SGD","02269","LU0708995583.HKD","LU0320764599.SGD","LU0516422366.SGD","LU0039217434.USD","LU0052750758.USD","LU0348735423.USD","LU0823426308.USD","SG9999002463.SGD","LU0572944931.SGD","LU0856984785.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704986","title":"Wuxi Biologics (Cayman) Stock Advances 3.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635704986?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:32","pubTimestamp":1778833920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 3.2% to 33.68 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.6% to 25962.73.Wuxi Biologics  Inc. closed 23% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 35.6 million shares, compared to the 50-day average of 28.7 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426480.USD","LU1688375341.USD","LU0708995583.HKD","LU1794554557.SGD","LU0516422440.USD","LU0516422952.EUR","LU1880383366.USD","BK1589","LU0456846285.SGD","LU0856984785.SGD","LU0417516738.SGD","BK1610","LU0417516902.SGD","LU0348825331.USD","LU0823426308.USD","BK1521","LU0052750758.USD","LU0572944931.SGD","LU0140636845.USD","LU1720050803.USD","02269","LU0348735423.USD","LU1242518857.USD","LU0039217434.USD","SG9999002562.SGD","LU0516422366.SGD","LU0516423174.USD","LU1242518931.SGD","LU0979878070.USD","LU0516423091.SGD","SG9999002463.SGD","LU0307460666.USD","LU0051755006.USD","LU0456827905.SGD","LU2039709279.SGD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0181495838.USD","LU0326950275.SGD","LU0359201612.USD","LU0359202008.SGD","LU0819121731.USD","BK1576","BK1141","LU0588546209.SGD","LU0043850808.USD","LU0327786744.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635792837","title":"Wuxi Biologics (Cayman) Stock Slips 3.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2635792837","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635792837?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:31","pubTimestamp":1778747460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 3.6% to 32.64 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 26389.04.The stock's fall snapped a three-day winning streak.Wuxi Biologics  Inc. closed 26% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 27.0 million shares, compared to the 50-day average of 28.9 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0417516738.SGD","LU1242518857.USD","LU0348825331.USD","LU0572944931.SGD","LU0823426308.USD","LU1242518931.SGD","LU2039709279.SGD","LU0456846285.SGD","LU0359201612.USD","BK1589","LU0052750758.USD","LU0516422440.USD","LU0348735423.USD","LU0140636845.USD","LU0823426480.USD","LU0979878070.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516423174.USD","LU0516422952.EUR","LU0327786744.USD","LU0516423091.SGD","LU0320764599.SGD","LU0359202008.SGD","LU0819121731.USD","LU1720050803.USD","LU0326950275.SGD","BK1610","IE00B0JY6N72.USD","LU0516422366.SGD","LU0039217434.USD","LU0588546209.SGD","LU0051755006.USD","LU0856984785.SGD","LU0043850808.USD","BK1576","LU0307460666.USD","LU1688375341.USD","BK1141","LU0181495838.USD","LU0456827905.SGD","02269","LU1880383366.USD","LU0417516902.SGD","LU3063872942.SGD","SG9999002562.SGD","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635737562","title":"WuXi Biologics enters 2026 Dow Jones Best-in-Class World Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2635737562","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635737562?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:34","pubTimestamp":1778643257,"startTime":"0","endTime":"0","summary":"Included in 2026 Dow Jones Best-in-Class Emerging Markets Index.Selection follows S&P Global Corporate Sustainability Assessment, which screens for top 10% performers on long-term economic, environmental, social metrics.Company ranked top 1% globally in its industry in 2025 CSA.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLbTvPz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","SG9999002463.SGD","LU0181495838.USD","LU0320764599.SGD","LU0979878070.USD","LU0039217434.USD","IE00B0JY6N72.USD","BK1589","BK1610","LU0708995583.HKD","LU0572944931.SGD","BK1576","LU0327786744.USD","LU0326950275.SGD","LU0516422366.SGD","LU0516422952.EUR","LU0052750758.USD","LU0456846285.SGD","LU1242518857.USD","LU1720050803.USD","LU0140636845.USD","LU0516423174.USD","LU0307460666.USD","LU0359201612.USD","LU0348735423.USD","LU0043850808.USD","LU1688375341.USD","SG9999002562.SGD","LU0823426480.USD","LU0516423091.SGD","LU0051755006.USD","LU1242518931.SGD","LU0823426308.USD","LU0856984785.SGD","LU0348825331.USD","LU0588546209.SGD","LU0456827905.SGD","LU0417516902.SGD","BK1141","LU0819121731.USD","LU3063872942.SGD","02269","LU0417516738.SGD","LU0516422440.USD","LU1794554557.SGD","LU0359202008.SGD","LU2039709279.SGD","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161500414","title":"Citigroup: Fundamentals of China's Healthcare Sector Show Sustained Improvement, Top Picks Include WuXi AppTec (02359)","url":"https://stock-news.laohu8.com/highlight/detail?id=1161500414","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161500414?lang=en_us&edition=fundamental","pubTime":"2026-05-11 17:00","pubTimestamp":1778490036,"startTime":"0","endTime":"0","summary":"Citigroup has released a research report stating that the past fiscal year and the first-quarter earnings season confirm a sustained improvement in the fundamentals of China's healthcare industry....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","02269","IE0008368742.USD","LU2417539215.USD","LU0455707207.USD","IE00B031HY20.USD","LU0708995583.HKD","IE00B5MMRT66.SGD","LU0072913022.USD","SG9999002562.SGD","BK1583","LU0310800965.SGD","LU0052750758.USD","LU0572944931.SGD","LU0072461881.USD","IE00BZ08YS42.EUR","LU2360032135.SGD","LU2488822045.USD","LU1993786604.SGD","LU2097828474.EUR","LU0516422440.USD","LU0130517989.USD","LU0516422366.SGD","LU1152091168.USD","LU2045819591.USD","LU2242644610.SGD","01801","LU0516423174.USD","LU1794554557.SGD","LU0130102774.USD","LU1791807156.HKD","BK1191","BK1515","LU2125154935.USD","BK4588","LU0051755006.USD","LU1152091754.HKD","LU0588546209.SGD","01672","IE00BZ08YT58.USD","LU0359201612.USD","LU0823426308.USD","LU1303224171.USD","SG9999004220.SGD","LU1719994722.HKD","LU2125910500.SGD","LU2495084118.USD","LU1244550494.USD","LU0140636845.USD","LU0501845795.SGD","LU0456846285.SGD","LU1808992512.USD","LU1226288253.USD","01276","C","LU3063872942.SGD","LU0098860793.USD","LU1251922891.USD","LU0348767384.USD","LU0106831901.USD","LU2097828557.USD","LU0516423091.SGD","LU0203347892.USD","LU1162221912.USD","LU1242518857.USD","BK1521","LU0320764599.SGD","LU0052756011.USD","LU1969619763.USD","LU0819121731.USD","02359","BK4207","BK4566","LU1720050803.USD","LU0043850808.USD","IE00BSNM7G36.USD","LU0417516902.SGD","LU1997245094.SGD","LU0320765646.SGD","HK0000165453.HKD","LU1023057109.AUD","LU1960683339.HKD","BK1161","LU1244550221.USD","BK1576","LU0314109678.HKD","LU0359202008.SGD","LU1506573853.SGD","LU1951186391.HKD","LU2125154778.USD","LU0456842615.SGD","LU0170899867.USD","LU0307460666.USD","LU1807302812.USD","LU1880383366.USD","LU1934453819.USD","BK1574","BK4585","SG9999002463.SGD","LU0314106906.USD","LU1997245177.USD","LU1226287792.SGD","LU0348766576.USD","LU1244550577.SGD","LU0067412154.USD","LU1226287875.USD","IE0008369823.USD","LU0359201885.HKD","BK4504","LU1008478684.HKD","LU2039709279.SGD","LU0477156953.USD","BK0216","LU0128525689.USD","LU2097828631.EUR","BK4534","LU1242518931.SGD","LU1201861249.SGD","LU0417516738.SGD","BK4559","LU2236285917.USD","LU2097828805.USD","LU0456827905.SGD","LU0980610538.SGD","LU2328871848.SGD","LU1267930227.SGD","LU2097828714.EUR","LU0162691827.USD","LU0823426480.USD","LU1328277881.USD","LU0315179316.USD","LU1770034418.SGD","LU1997244956.HKD","BK1141","603259","LU0502904849.HKD","LU1046422090.SGD","LU2462157665.USD","LU0203345920.USD","LU0856984785.SGD","LU1979443071.USD","LU0327786744.USD","LU1688375341.USD","BK1610","LU0880133367.SGD","LU0181495838.USD","BK1589","LU0648001328.SGD","LU0326950275.SGD","LU0348735423.USD","LU0348825331.USD","LU0516422952.EUR","IE00BZ08YR35.GBP","LU2543165471.USD","LU1226288170.HKD","LU1813983027.USD","IE00B543WZ88.USD","01093","LU1226287529.USD","LU0039217434.USD","LU2456880835.USD","LU1366192091.USD","IE00B0JY6N72.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634099594","title":"Wuxi Biologics (Cayman) Stock Climbs 1.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2634099594","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634099594?lang=en_us&edition=fundamental","pubTime":"2026-05-11 16:33","pubTimestamp":1778488380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 1.2% to 33.06 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 26406.84.Wuxi Biologics  Inc. closed 25% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 22.6 million shares, compared to the 50-day average of 29.5 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423091.SGD","BK1521","LU0979878070.USD","LU1242518931.SGD","LU3063872942.SGD","LU0572944931.SGD","LU0348825331.USD","LU0181495838.USD","LU0359201612.USD","IE00B0JY6N72.USD","BK1589","LU1688375341.USD","LU0327786744.USD","LU0359202008.SGD","LU0516422366.SGD","LU0052750758.USD","02269","LU0417516738.SGD","LU0823426308.USD","BK1576","LU1794554557.SGD","LU0320764599.SGD","LU0043850808.USD","SG9999002562.SGD","BK1610","LU2039709279.SGD","LU0588546209.SGD","BK1141","LU0819121731.USD","LU0516422440.USD","LU0456846285.SGD","LU0516422952.EUR","LU0708995583.HKD","LU0417516902.SGD","LU1720050803.USD","LU0348735423.USD","LU1242518857.USD","LU0039217434.USD","LU0516423174.USD","LU0307460666.USD","LU0456827905.SGD","LU1880383366.USD","LU0823426480.USD","SG9999002463.SGD","LU0140636845.USD","LU0051755006.USD","LU0856984785.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166588783","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166588783","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166588783?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:30","pubTimestamp":1778477425,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","01672","02269","06978","09606","09688","02268","09995","03759","09966","02137","06606","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634498241","title":"WuXi Biologics Chengdu Milestone Raises Questions On Capacity Use And Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2634498241","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634498241?lang=en_us&edition=fundamental","pubTime":"2026-05-09 03:24","pubTimestamp":1778268293,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) reached structural completion of its new microbial commercial manufacturing facility in Chengdu.\nThe company has taken delivery of key equipment at the site, moving closer to GMP-ready large-scale production of microbial-derived biologics targeted by the end of 2026.\nThe Chengdu facility includes China's first dual-chamber lyophilization production line and high automation to support complex biologics manufacturing and efficiency.\nESG-focused green building practices...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-chengdu-milestone-raises-questions-on-capacit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-chengdu-milestone-raises-questions-on-capacit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1589","SG9999002562.SGD","LU0823426308.USD","LU0043850808.USD","LU0572944931.SGD","IE00B0JY6N72.USD","LU0140636845.USD","LU0516422952.EUR","LU0856984785.SGD","BK1521","LU0052750758.USD","02269","LU1688375341.USD","LU0456846285.SGD","LU0417516738.SGD","LU1242518857.USD","LU0348825331.USD","BK1576","LU3063872942.SGD","SG9999002463.SGD","LU0359202008.SGD","BK1610","LU0708995583.HKD","LU0307460666.USD","LU0181495838.USD","LU0051755006.USD","LU0326950275.SGD","LU0320764599.SGD","LU0327786744.USD","LU0979878070.USD","LU1242518931.SGD","LU1880383366.USD","LU0456827905.SGD","LU0516422440.USD","LU0516423174.USD","LU1720050803.USD","LU0516423091.SGD","LU0823426480.USD","BK1141","LU1794554557.SGD","LU0516422366.SGD","LU0359201612.USD","LU0039217434.USD","LU0348735423.USD","LU0819121731.USD","LU0417516902.SGD","LU2039709279.SGD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633435697","title":"Wuxi Biologics (Cayman) Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435697","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633435697?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:32","pubTimestamp":1778229120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 1.9% to 32.66 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 26393.71.Wuxi Biologics  Inc. closed 26% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 30.1 million shares, compared to the 50-day average of 29.1 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","LU0320764599.SGD","LU0348825331.USD","LU1720050803.USD","02269","LU0856984785.SGD","LU0140636845.USD","LU0039217434.USD","LU0417516738.SGD","BK1589","SG9999002562.SGD","LU0516422952.EUR","LU0516423174.USD","LU1880383366.USD","BK1521","LU0588546209.SGD","LU3063872942.SGD","LU0572944931.SGD","BK1610","LU0348735423.USD","LU0327786744.USD","LU1242518857.USD","LU0516423091.SGD","LU0326950275.SGD","LU0417516902.SGD","LU1242518931.SGD","IE00B0JY6N72.USD","LU0823426308.USD","LU0181495838.USD","LU0359201612.USD","LU0307460666.USD","LU0359202008.SGD","BK1576","LU0043850808.USD","LU0819121731.USD","LU1794554557.SGD","LU0979878070.USD","LU1688375341.USD","LU0051755006.USD","LU2039709279.SGD","LU0708995583.HKD","LU0823426480.USD","LU0052750758.USD","LU0516422366.SGD","BK1141","SG9999002463.SGD","LU0516422440.USD","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186785441","title":"WUXI BIO issues 3.03 million new shares in April via Pre-IPO option exercises, total share count rises to 4.14 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1186785441","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186785441?lang=en_us&edition=fundamental","pubTime":"2026-05-07 22:22","pubTimestamp":1778163770,"startTime":"0","endTime":"0","summary":"For the month ended 30 April 2026, WuXi Biologics (Cayman) Inc. (WUXI BIO) reported a net issuance of 3.03 million ordinary shares, all arising from exercises under its Pre-IPO Share Option Scheme....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144325","title":"Whitehawk Q1 net loss turns to USD 22.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144325","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144325?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:04","pubTimestamp":1778155486,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics posted a net loss of USD 22.2 million, swinging from net income of USD 73 million a year earlier.Research and development expenses climbed to USD 17.2 million from USD 8.8 million, including USD 5.3 million of development milestone expenses under a license agreement with WuXi Biologics.Cash, cash equivalents, short-term investments fell to USD 123 million at March 31 from USD 145.7 million at Dec. 31; cash runway seen funding operations into 2028.Phase 1 dose-escalation studies for HWK-007 and HWK-016 continued enrolling; IND submission for HWK-206 remains on track for mid-2026 with Phase 1 recruitment planned to start in Q3 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL6tttYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0043850808.USD","BK1589","LU1720050803.USD","WHWK","LU0320764599.SGD","LU0516422952.EUR","BK1141","BK1576","LU0588546209.SGD","LU0140636845.USD","LU0856984785.SGD","LU1688375341.USD","LU0516423174.USD","LU0359201612.USD","LU0348825331.USD","LU0327786744.USD","02269","BK1610","LU1880383366.USD","LU0181495838.USD","LU0417516738.SGD","LU0823426308.USD","LU3063872942.SGD","LU0052750758.USD","LU0039217434.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0516423091.SGD","LU0823426480.USD","LU2039709279.SGD","LU1242518857.USD","SG9999002463.SGD","LU0516422366.SGD","LU0979878070.USD","LU0572944931.SGD","LU0307460666.USD","LU0348735423.USD","LU0819121731.USD","LU0417516902.SGD","SG9999002562.SGD","LU1242518931.SGD","LU0326950275.SGD","LU0456846285.SGD","LU0708995583.HKD","LU1794554557.SGD","LU0516422440.USD","LU0359202008.SGD","BK4139","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633907782","title":"Wuxi Biologics (Cayman) Stock Slips 2.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633907782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633907782?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:32","pubTimestamp":1778056320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 2.5% to 32.98 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 26213.78.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 25% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 31.6 million shares, compared to the 50-day average of 28.2 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423091.SGD","LU1688375341.USD","LU0039217434.USD","LU0320764599.SGD","LU2039709279.SGD","LU0359202008.SGD","LU0307460666.USD","LU0588546209.SGD","LU0327786744.USD","LU0516423174.USD","SG9999002463.SGD","LU0708995583.HKD","LU0348825331.USD","LU0819121731.USD","LU1794554557.SGD","LU1242518931.SGD","LU0979878070.USD","LU0052750758.USD","LU0516422366.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0516422440.USD","LU0051755006.USD","LU1720050803.USD","LU0417516738.SGD","LU0326950275.SGD","BK1141","LU0823426480.USD","LU1880383366.USD","LU0348735423.USD","LU0359201612.USD","LU0456846285.SGD","LU0456827905.SGD","LU0516422952.EUR","BK1521","BK1576","LU3063872942.SGD","LU0823426308.USD","02269","BK1610","LU0417516902.SGD","LU1242518857.USD","BK1589","IE00B0JY6N72.USD","LU0043850808.USD","LU0140636845.USD","LU0856984785.SGD","LU0181495838.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633185139","title":"Wuxi Biologics (Cayman) Stock Slides 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185139","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633185139?lang=en_us&edition=fundamental","pubTime":"2026-05-05 16:31","pubTimestamp":1777969860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 2.1% to 33.84 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25898.61.Wuxi Biologics  Inc. closed 23% below its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 10.2 million shares, compared to the 50-day average of 28.8 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","LU1688375341.USD","LU0039217434.USD","LU3063872942.SGD","LU0823426480.USD","LU0326950275.SGD","LU0327786744.USD","LU0348825331.USD","LU0417516738.SGD","LU0456846285.SGD","LU1242518931.SGD","LU0823426308.USD","LU1242518857.USD","LU2039709279.SGD","LU0348735423.USD","LU0588546209.SGD","BK1589","LU0819121731.USD","LU0572944931.SGD","BK1141","LU0181495838.USD","LU0856984785.SGD","LU0320764599.SGD","LU1720050803.USD","LU0140636845.USD","LU0456827905.SGD","LU0516422366.SGD","LU0979878070.USD","LU0307460666.USD","LU0359201612.USD","LU0516422440.USD","BK1576","LU0516422952.EUR","LU0052750758.USD","LU0051755006.USD","LU0708995583.HKD","LU1880383366.USD","IE00B0JY6N72.USD","BK1521","LU0359202008.SGD","02269","LU0516423091.SGD","SG9999002463.SGD","LU1794554557.SGD","LU0516423174.USD","LU0043850808.USD","BK1610","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632939668","title":"Wuxi Biologics (Cayman) Stock Climbs 4.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2632939668","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632939668?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:30","pubTimestamp":1777883400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 4.6% to 34.56 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 26095.88.Wuxi Biologics  Inc. closed 21% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 16.5 million shares, compared to the 50-day average of 29.9 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0JY6N72.USD","LU0181495838.USD","LU0348825331.USD","LU0572944931.SGD","LU0856984785.SGD","LU1880383366.USD","LU0708995583.HKD","LU0359201612.USD","LU0320764599.SGD","LU0456846285.SGD","LU0516423091.SGD","LU0516422440.USD","LU1688375341.USD","LU0456827905.SGD","LU2039709279.SGD","BK1141","LU0039217434.USD","LU0516423174.USD","LU0052750758.USD","LU0819121731.USD","LU0516422952.EUR","BK1576","SG9999002463.SGD","BK1610","LU1794554557.SGD","LU0043850808.USD","LU0140636845.USD","02269","LU1242518931.SGD","LU0823426480.USD","LU0979878070.USD","BK1521","LU0307460666.USD","LU0417516738.SGD","LU0588546209.SGD","LU0516422366.SGD","LU1720050803.USD","BK1589","LU0417516902.SGD","LU0359202008.SGD","LU0051755006.USD","LU0823426308.USD","LU3063872942.SGD","LU0327786744.USD","LU1242518857.USD","LU0326950275.SGD","LU0348735423.USD","SG9999002562.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186912312","title":"Stock Track | WuXi Biologics Soars 5.08% Intraday on Strong Annual Results and Positive Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1186912312","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186912312?lang=en_us&edition=fundamental","pubTime":"2026-05-04 11:10","pubTimestamp":1777864228,"startTime":"0","endTime":"0","summary":"WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.The surge follows the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628760","title":"Is WuXi Biologics (SEHK:2269) Attractive After Its Five Year Share Price Reset?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628760","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628760?lang=en_us&edition=fundamental","pubTime":"2026-05-02 02:52","pubTimestamp":1777661523,"startTime":"0","endTime":"0","summary":"If you are wondering whether WuXi Biologics (Cayman) is priced attractively right now, it helps to start with a clear view of what the market has been paying for the stock and why.\nThe share price last closed at HK$33.04, with returns of a 2.6% decline over 7 days, 0.1% over 30 days, 1.5% year to date, 44.9% over 1 year, a 29.5% decline over 3 years, and a 68.9% decline over 5 years, a mix that can signal changing expectations around both growth potential and risk.\nRecent coverage has...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/is-wuxi-biologics-sehk2269-attractive-after-its-five-year-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/is-wuxi-biologics-sehk2269-attractive-after-its-five-year-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2039709279.SGD","BK1610","LU0823426308.USD","LU0516422366.SGD","LU0516422440.USD","LU1242518931.SGD","LU0043850808.USD","BK1141","LU0307460666.USD","IE00B0JY6N72.USD","LU0039217434.USD","LU0516422952.EUR","DCF","LU0359202008.SGD","LU0516423091.SGD","LU0051755006.USD","LU0348825331.USD","BK1521","LU0708995583.HKD","LU0819121731.USD","LU0856984785.SGD","LU1242518857.USD","LU3063872942.SGD","LU1794554557.SGD","LU1720050803.USD","BK1576","02269","LU0572944931.SGD","LU0417516738.SGD","LU0359201612.USD","SG9999002562.SGD","LU0823426480.USD","LU0588546209.SGD","LU0348735423.USD","LU1880383366.USD","LU0052750758.USD","LU0417516902.SGD","LU0140636845.USD","BK1589","LU0181495838.USD","LU0320764599.SGD","LU0516423174.USD","LU0327786744.USD","LU0456846285.SGD","LU1688375341.USD","LU0456827905.SGD","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631685094","title":"Wuxi Biologics (Cayman) Stock Sheds 2.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2631685094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631685094?lang=en_us&edition=fundamental","pubTime":"2026-04-30 16:32","pubTimestamp":1777537920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 2.7% to 33.04 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25776.53.The stock's fall snapped a two-day winning streak.Wuxi Biologics  Inc. closed 25% short of its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 34.2 million shares, compared to the 50-day average of 29.9 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK1610","LU0823426308.USD","LU0516422366.SGD","LU0516422440.USD","LU1242518931.SGD","LU0043850808.USD","BK1141","LU0307460666.USD","IE00B0JY6N72.USD","LU0039217434.USD","LU0516422952.EUR","LU0359202008.SGD","LU0516423091.SGD","LU0051755006.USD","LU0348825331.USD","BK1521","LU0708995583.HKD","LU0819121731.USD","LU0856984785.SGD","LU1242518857.USD","LU3063872942.SGD","LU1794554557.SGD","LU1720050803.USD","BK1576","02269","LU0572944931.SGD","LU0417516738.SGD","LU0359201612.USD","SG9999002562.SGD","LU0823426480.USD","LU0588546209.SGD","LU0348735423.USD","LU1880383366.USD","LU0052750758.USD","LU0417516902.SGD","LU0140636845.USD","BK1589","LU0181495838.USD","LU0320764599.SGD","LU0516423174.USD","LU0327786744.USD","LU0456846285.SGD","LU1688375341.USD","LU0456827905.SGD","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631928635","title":"WuXi Biologics publishes 2025 sustainability report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631928635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631928635?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:31","pubTimestamp":1777458687,"startTime":"0","endTime":"0","summary":"WuXi Biologics released Sustainability Report 2025, outlining strategy across governance, social impact, workforce, climate.Company introduced greenhouse-gas target matrix validated by Science Based Targets initiative, covering Scope 1, Scope 2, Scope 3.Scope 1 and Scope 2 emissions intensity fell 30% from 2020 baseline.Water consumption intensity decreased 32% versus 2019 baseline, surpassing 30% reduction target.Supply-chain program reached ISO 20400 sustainable procurement certification, with 81% of global suppliers by spend covered in annual sustainability risk assessment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics  Inc. published the original content used to generate this news brief via IIS, the Issuer Informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL64h3Vz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU0307460666.USD","LU0516422366.SGD","LU0039217434.USD","LU0708995583.HKD","LU1242518857.USD","BK1610","LU0456846285.SGD","IE00B0JY6N72.USD","02269","LU0516423091.SGD","LU0588546209.SGD","LU1688375341.USD","BK1521","LU1720050803.USD","LU0348735423.USD","LU0516422440.USD","LU0043850808.USD","LU0572944931.SGD","BK1576","LU0979878070.USD","LU0359201612.USD","LU0516423174.USD","LU0052750758.USD","LU3063872942.SGD","LU1880383366.USD","BK1141","LU0140636845.USD","LU0051755006.USD","LU0856984785.SGD","BK1589","LU0819121731.USD","LU0823426480.USD","LU1794554557.SGD","LU0823426308.USD","LU0181495838.USD","LU0516422952.EUR","LU0417516902.SGD","LU0326950275.SGD","LU0327786744.USD","LU0348825331.USD","LU0456827905.SGD","LU1242518931.SGD","SG9999002562.SGD","LU0320764599.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107263466","title":"WuXi Biologics 2025年业绩稳健增长：年收入达217.90亿元，净利润同比升45.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107263466","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107263466?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:50","pubTimestamp":1777452647,"startTime":"0","endTime":"0","summary":"根据WuXi Biologics (Cayman) Inc.（“公司”）发布的2025年年度报告，得益于一体化CRDMO平台在全球生物医药领域的持续拓展，报告期内公司经营表现显著提升，核心业务稳步增长。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"WuXi Biologics 2025年业绩稳健增长：年收入达217.90亿元，净利润同比升45.3%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582812","title":"Assessing WuXi Biologics (SEHK:2269) Valuation As Undervaluation Narrative Gains Traction","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582812","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631582812?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:12","pubTimestamp":1777389158,"startTime":"0","endTime":"0","summary":"What WuXi Biologics (Cayman) SEHK:2269 offers investors right now\nWuXi Biologics (Cayman) SEHK:2269 gives you exposure to a global contract research, development, and manufacturing business in biologics, backed by HK$21,790.018 million in revenue and HK$4,908.343 million in net income.\nSee our latest analysis for WuXi Biologics (Cayman).\nAt a share price of HK$33.7, WuXi Biologics (Cayman) has a 30 day share price return of 4.14%, while the 1 year total shareholder return of 45.89% contrasts...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-as-undervaluatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-as-undervaluatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0516422952.EUR","LU2039709279.SGD","LU0856984785.SGD","LU3063872942.SGD","LU0052750758.USD","LU0043850808.USD","LU0359201612.USD","LU0181495838.USD","LU0326950275.SGD","02269","LU0572944931.SGD","LU0417516738.SGD","LU0588546209.SGD","LU0819121731.USD","LU0327786744.USD","LU0417516902.SGD","LU0516423174.USD","LU1242518857.USD","LU0140636845.USD","LU0359202008.SGD","LU0708995583.HKD","LU0320764599.SGD","LU0823426308.USD","LU0516422366.SGD","LU0307460666.USD","LU0039217434.USD","LU1688375341.USD","LU0456827905.SGD","LU0051755006.USD","BK1576","IE00B0JY6N72.USD","BK1521","LU0516423091.SGD","LU0516422440.USD","LU1794554557.SGD","LU0348735423.USD","LU1242518931.SGD","LU1880383366.USD","SG9999002562.SGD","LU0456846285.SGD","BK1589","LU0348825331.USD","LU0979878070.USD","BK1141","BK1610","LU1720050803.USD","SG9999002463.SGD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0778},{"period":"3month","weight":-0.1867},{"period":"6month","weight":0.032},{"period":"1year","weight":0.3987},{"period":"ytd","weight":0.0477}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0185},{"period":"3month","weight":-0.0386},{"period":"6month","weight":-0.006},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0017}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.444444,"avgChangeRate":0.001139},{"month":6,"riseRate":0.625,"avgChangeRate":0.064583},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}